Want to join the conversation?
During 3Q15, $IRM implemented plan that calls for certain organizational realignments to cut overhead costs, particularly in developed markets, in order to optimize selling, general and administrative, or SG&A, cost structure and to support investments to advance growth strategy. $IRM recorded charge in SG&A expenses of about $9,100 during 3Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.